A single view of all the companies in the same space to infer if the stock is undervalued, overvalued or priced right. This would be one way to analyze a longer terms investment in a particular sector.
| Company | Market Cap | Income | Sales | P/E | P/B | Cash/Share | Dividend | Dividend Yield | Price To Cash Ratio | Debt to Equity Ratio | ROE | ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zosano Pharma Corporation | 13,300,000 | -29,900,000 | 800,000 | 0.00 | 0.23 | 1.84 | - | - | 1.21 | 0.15 | -76.10% | -52.10% |
| Abeona Therapeutics Inc. | 36,430,000 | -84,900,000 | 3,000,000 | 0.00 | 0.49 | 0.30 | - | - | 0.81 | 0.00 | -109.70% | -72.20% |
| Aeterna Zentaris Inc. | 38,790,000 | -8,400,000 | 5,300,000 | 0.00 | 0.69 | 0.51 | - | - | 0.59 | 0.00 | -14.00% | -10.00% |
| AgeX Therapeutics, Inc. | 38,470,000 | -8,600,000 | 100,000 | 0.00 | 0.00 | 0.02 | - | - | 64.12 | 0.00 | 96.20% | -307.60% |
| AIkido Pharma Inc. | 29,150,000 | -7,200,000 | 0 | 0.00 | 0.28 | 0.92 | - | - | 0.35 | 0.00 | -7.00% | -6.90% |
| AIM ImmunoTech Inc. | 49,450,000 | -19,100,000 | 100,000 | 0.00 | 0.89 | 1.02 | - | - | 1.02 | 0.00 | -30.30% | -29.20% |
| Allarity Therapeutics, Inc. | 16,030,000 | 0 | -7,130,000 | 0.00 | 5.88 | 0.65 | - | - | 2.81 | 0.00 | - | - |
| Allena Pharmaceuticals, Inc. | 20,340,000 | -48,700,000 | 0 | 0.00 | 0.84 | 0.29 | - | - | 0.68 | 0.52 | -241.30% | -130.30% |
| Aileron Therapeutics, Inc. | 51,470,000 | -26,200,000 | 0 | 0.00 | 1.12 | 0.48 | - | - | 1.12 | 0.00 | -49.50% | -45.80% |
| Ampio Pharmaceuticals, Inc. | 79,500,000 | -17,100,000 | 0 | 0.00 | 2.22 | 0.12 | - | - | 2.35 | 0.00 | -83.60% | -62.20% |
| Ardelyx, Inc. | 132,470,000 | -158,200,000 | 10,100,000 | 0.00 | 1.37 | 0.87 | - | - | 1.14 | 0.39 | -153.40% | -86.00% |
| Artelo Biosciences, Inc. | 17,280,000 | -10,000,000 | 0 | 0.00 | 0.46 | 0.52 | - | - | 0.71 | 0.00 | -54.00% | -52.10% |
| Alterity Therapeutics Limited | 33,830,000 | -11,300,000 | 4,340,000 | 0.00 | 0.85 | 0.62 | - | - | 1.24 | 0.00 | - | - |
| Athersys, Inc. | 126,400,000 | -87,000,000 | 5,500,000 | 0.00 | 7.51 | 0.16 | - | - | 3.38 | 0.00 | -301.30% | -125.20% |
| Avenue Therapeutics, Inc. | 12,120,000 | -3,700,000 | 0 | 0.00 | 2.50 | 0.15 | - | - | 3.19 | 0.00 | -276.00% | -191.80% |
| Aura Biosciences, Inc. | 545,760,000 | -46,200,000 | 0 | 0.00 | 3.37 | 4.80 | - | - | 3.66 | 0.00 | - | - |
| Avalo Therapeutics, Inc. | 67,480,000 | -84,400,000 | 5,400,000 | 0.00 | 2.95 | 0.00 | - | - | 0.00 | 1.42 | -285.70% | -111.40% |
| Brickell Biotech, Inc. | 36,190,000 | -39,500,000 | 400,000 | 0.00 | 1.14 | 0.19 | - | - | 1.35 | 0.00 | -163.80% | -129.60% |
| Bionomics Limited | 60,090,000 | 0 | 930,000 | 0.00 | 8.79 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Calithera Biosciences, Inc. | 23,090,000 | -115,100,000 | 9,800,000 | 0.00 | 2.50 | 0.71 | - | - | 0.39 | 0.00 | -177.10% | -126.70% |
| CASI Pharmaceuticals, Inc. | 80,290,000 | -36,700,000 | 30,200,000 | 0.00 | 0.93 | 0.34 | - | - | 1.65 | 0.00 | -40.10% | -25.80% |
| Catalyst Biosciences, Inc. | 15,750,000 | -87,900,000 | 7,300,000 | 0.00 | 0.43 | 1.65 | - | - | 0.34 | 0.00 | -120.80% | -99.10% |
| Cidara Therapeutics, Inc. | 55,080,000 | -42,500,000 | 49,600,000 | 0.00 | 2.34 | 0.84 | - | - | 0.92 | 0.12 | -445.90% | -69.50% |
| Cognition Therapeutics, Inc. | 65,360,000 | -16,200,000 | 0 | 0.00 | 1.44 | 2.55 | - | - | 1.19 | 0.00 | - | - |
| CinCor Pharma, Inc. | 913,200,000 | -50,400,000 | 0 | 0.00 | 0.00 | 3.81 | - | - | 6.69 | 0.00 | - | - |
| Caladrius Biosciences, Inc. | 39,600,000 | -27,500,000 | 0 | 0.00 | 0.42 | 1.53 | - | - | 0.42 | 0.00 | -27.10% | -26.00% |
| Cellectar Biosciences, Inc. | 38,220,000 | -24,100,000 | 0 | 0.00 | 1.10 | 0.53 | - | - | 1.07 | 0.00 | -67.80% | -53.00% |
| Celsion Corporation | 24,180,000 | -20,800,000 | 500,000 | 0.00 | 0.32 | 6.37 | - | - | 0.49 | 0.11 | -35.50% | -26.80% |
| CNS Pharmaceuticals, Inc. | 13,690,000 | -14,000,000 | 0 | 0.00 | 1.37 | 0.12 | - | - | 2.74 | 0.06 | -142.60% | -117.80% |
| Context Therapeutics Inc. | 26,840,000 | -10,500,000 | 0 | 0.00 | 0.53 | 2.98 | - | - | 0.54 | 0.00 | 287.90% | -71.50% |
| Cocrystal Pharma, Inc. | 53,420,000 | -14,200,000 | 510,000 | 0.00 | 0.66 | 0.57 | - | - | 0.91 | 0.00 | -19.20% | -18.70% |
| Corbus Pharmaceuticals Holdings, Inc. | 45,400,000 | -45,600,000 | 900,000 | 0.00 | 0.63 | 0.75 | - | - | 0.47 | 0.28 | -57.90% | -37.40% |
| CohBar, Inc. | 23,040,000 | -15,500,000 | 0 | 0.00 | 0.83 | 0.30 | - | - | 0.88 | 0.02 | -91.80% | -80.00% |
| Diffusion Pharmaceuticals Inc. | 16,440,000 | -24,100,000 | 0 | 0.00 | 20.76 | 17.43 | - | - | 0.44 | 0.00 | -54.50% | -51.40% |
| DICE Therapeutics, Inc. | 839,970,000 | -49,000,000 | 1,100,000 | 0.00 | 2.63 | 8.18 | - | - | 2.63 | 0.01 | - | - |
| Eloxx Pharmaceuticals, Inc. | 33,640,000 | -66,700,000 | 0 | 0.00 | 1.31 | 0.00 | - | - | 0.00 | 0.54 | -270.20% | -147.10% |
| Enveric Biosciences, Inc. | 16,329,999 | -49,000,000 | 0 | 0.00 | 0.40 | 0.29 | - | - | 0.94 | 0.00 | -169.60% | -134.20% |
| Evofem Biosciences, Inc. | 38,010,000 | -206,200,000 | 8,199,999 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | 491.60% | -264.30% |
| Exscientia plc | 1,670,000,000 | 0 | 27,170,000 | 0.00 | 0.01 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Genenta Science S.p.A. | 107,620,000 | -7,800,000 | 0 | 0.00 | 7.37 | 0.60 | - | - | 9.44 | 0.00 | - | - |
| Hoth Therapeutics, Inc. | 20,240,000 | -14,300,000 | 0 | 0.00 | 1.47 | 0.31 | - | - | 1.95 | 0.00 | -95.80% | -87.80% |
| Histogen Inc. | 11,030,000 | -15,000,000 | 1,000,000 | 0.00 | 0.43 | 0.35 | - | - | 0.59 | 0.00 | -66.50% | -52.30% |
| iBio, Inc. | 76,970,000 | -28,600,000 | 1,600,000 | 0.00 | 0.77 | 0.24 | - | - | 1.34 | 0.24 | -28.30% | -20.40% |
| Idera Pharmaceuticals, Inc. | 25,100,000 | 96,900,000 | 0 | 0.36 | 0.81 | 0.59 | - | - | 0.77 | 0.00 | 272.10% | 232.90% |
| Immix Biopharma, Inc. | 24,380,000 | -24,400,000 | 0 | 0.00 | 0.61 | 1.10 | - | - | 1.39 | 0.01 | - | - |
| Immuron Limited | 17,300,000 | 0 | 150,000 | 0.00 | 0.67 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| MiNK Therapeutics, Inc. | 83,670,000 | -30,200,000 | 0 | 0.00 | 3.27 | 1.14 | - | - | 2.15 | 0.00 | - | - |
| IO Biotech, Inc. | 204,770,000 | -75,000,000 | 0 | 0.00 | 0.63 | 8.20 | - | - | 0.97 | 0.00 | - | - |
| Iterum Therapeutics plc | 52,600,000 | -91,600,000 | 0 | 0.00 | 1.01 | 0.42 | - | - | 0.65 | 0.53 | -201.90% | -89.10% |
| Jaguar Health, Inc. | 40,680,000 | -52,600,000 | 4,300,000 | 0.00 | 1.93 | 0.20 | - | - | 2.38 | 2.43 | -217.20% | -83.90% |
| Kala Pharmaceuticals, Inc. | 59,700,000 | -142,600,000 | 11,200,000 | 0.00 | 3.10 | 1.15 | - | - | 0.65 | 4.70 | -209.50% | -73.30% |
| Kiora Pharmaceuticals, Inc. | 7,160,000 | -16,399,999 | 10,000 | 0.00 | 0.71 | 0.57 | - | - | 0.91 | 0.00 | -131.90% | -79.70% |
| Kintara Therapeutics, Inc. | 15,200,000 | -27,700,000 | 0 | 0.00 | 10.10 | 0.28 | - | - | 1.08 | 0.00 | - | -152.90% |
| Pasithea Therapeutics Corp. | 28,340,000 | -2,200,000 | 0 | 27.21 | 0.06 | 2.19 | - | - | 0.53 | 0.00 | -12.60% | -11.40% |
| LianBio | 524,890,000 | -196,300,000 | 0 | 0.00 | 1.42 | 3.48 | - | - | 1.37 | 0.00 | - | - |
| Stealth BioTherapeutics Corp | 32,530,000 | -52,500,000 | 0 | 0.00 | 0.00 | 0.71 | - | - | 0.69 | 0.00 | 186.70% | -130.10% |
| Marker Therapeutics, Inc. | 29,770,000 | -41,900,000 | 1,200,000 | 0.00 | 0.63 | 0.48 | - | - | 0.70 | 0.00 | -72.20% | -54.20% |
| Matinas BioPharma Holdings, Inc. | 175,820,000 | -23,700,000 | 100,000 | 0.00 | 3.42 | 0.23 | - | - | 3.54 | 0.00 | -40.00% | -35.00% |
| Nabriva Therapeutics plc | 21,930,000 | -49,500,000 | 28,900,000 | 0.00 | 0.35 | 0.72 | - | - | 0.46 | 0.15 | -82.10% | -57.40% |
| NovaBay Pharmaceuticals, Inc. | 12,440,000 | -6,600,000 | 8,400,000 | 0.00 | 1.16 | 0.15 | - | - | 1.66 | 0.01 | -63.90% | -41.10% |
| NeuroSense Therapeutics Ltd. | 23,400,000 | -4,000,000 | 0 | 0.00 | 2.85 | 1.11 | - | - | 2.11 | 0.00 | - | - |
| Nutriband Inc. | 0 | 0 | 1,390,000 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| InVivo Therapeutics Holdings Corp. | 7,830,000 | -9,900,000 | 0 | 0.00 | 0.41 | 0.52 | - | - | 0.41 | 0.00 | -45.00% | -40.00% |
| Oragenics, Inc. | 43,990,000 | -15,700,000 | 0 | 0.00 | 1.77 | 0.22 | - | - | 1.61 | 0.01 | -55.50% | -47.60% |
| OncoSec Medical Incorporated | 41,070,000 | -41,000,000 | 0 | 0.00 | 1.72 | 0.53 | - | - | 1.63 | 0.03 | -122.20% | -81.70% |
| Phio Pharmaceuticals Corp. | 16,200,000 | -13,300,000 | 0 | 0.00 | 0.70 | 1.70 | - | - | 0.67 | 0.00 | -49.50% | -44.80% |
| Protalix BioTherapeutics, Inc. | 52,850,000 | 0 | 49,300,000 | 0.00 | 232.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| PolarityTE, Inc. | 19,050,000 | -30,200,000 | 9,400,000 | 0.00 | 0.87 | 0.21 | - | - | 0.97 | 0.03 | -119.30% | -67.90% |
| Palatin Technologies, Inc. | 101,640,000 | -35,500,000 | 700,000 | 0.00 | 2.66 | 0.19 | - | - | 2.15 | 0.01 | -74.40% | -54.40% |
| Pulmatrix, Inc. | 20,410,000 | -23,400,000 | 5,200,000 | 0.00 | 0.35 | 14.94 | - | - | 0.38 | 0.00 | -46.40% | -37.40% |
| Pyxis Oncology, Inc. | 93,180,000 | -76,000,000 | 0 | 0.00 | 0.33 | 8.17 | - | - | 0.34 | 0.00 | - | - |
| Regulus Therapeutics Inc. | 34,520,000 | -27,800,000 | 5,000,000 | 0.00 | 0.43 | 0.38 | - | - | 0.57 | 0.09 | -75.20% | -55.40% |
| RenovoRx, Inc. | 18,070,000 | -6,300,000 | 0 | 0.00 | 1.15 | 1.49 | - | - | 1.19 | 0.00 | - | -66.70% |
| Roivant Sciences Ltd. | 2,760,000,000 | -1,084,800,000 | 61,200,000 | 0.00 | 1.49 | 3.25 | - | - | 1.25 | 0.11 | - | - |
| Salarius Pharmaceuticals, Inc. | 17,010,000 | -12,800,000 | 1,800,000 | 0.00 | 0.33 | 0.48 | - | - | 0.58 | 0.00 | -29.00% | -27.90% |
| Soligenix, Inc. | 27,230,000 | -12,600,000 | 800,000 | 0.00 | 2.27 | 0.54 | - | - | 1.05 | 0.93 | -85.50% | -42.60% |
| Sonnet BioTherapeutics Holdings, Inc. | 19,610,000 | -25,300,000 | 600,000 | 0.00 | 1.18 | 0.31 | - | - | 1.01 | 0.00 | -240.80% | -156.90% |
| Surrozen, Inc. | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - |
| Synthetic Biologics, Inc. | 32,130,000 | -23,200,000 | 0 | 0.00 | 0.50 | 0.51 | - | - | 0.48 | 0.00 | -31.50% | -30.70% |
| Theseus Pharmaceuticals, Inc. | 447,150,000 | -27,300,000 | 0 | 0.00 | 1.86 | 5.93 | - | - | 1.83 | 0.00 | - | - |
| Tiziana Life Sciences PLC | 15,130,000 | -37,800,000 | -3,600,000 | 0.00 | 2.89 | 2.98 | - | - | 0.30 | 0.02 | -141.90% | -109.40% |
| Timber Pharmaceuticals, Inc. | 17,840,000 | -10,800,000 | 900,000 | 0.00 | 1.09 | 0.26 | - | - | 1.06 | 0.00 | -197.80% | -107.90% |
| Tonix Pharmaceuticals Holding Corp. | 94,860,000 | -92,300,000 | 0 | 0.00 | 0.33 | 0.30 | - | - | 0.53 | 0.00 | -47.40% | -44.60% |
| Entrada Therapeutics, Inc. | 231,340,000 | -51,200,000 | 0 | 0.00 | 0.15 | 9.19 | - | - | 0.79 | 0.00 | - | - |
| Trevena, Inc. | 59,940,000 | -51,600,000 | 600,000 | 0.00 | 0.85 | 0.37 | - | - | 0.90 | 0.00 | -62.40% | -51.30% |
| Tyme Technologies, Inc. | 59,040,000 | -24,000,000 | 0 | 0.00 | 0.66 | 0.42 | - | - | 0.79 | 0.00 | -25.50% | -23.70% |
| Tyra Biosciences, Inc. | 357,150,000 | -26,300,000 | 0 | 0.00 | 0.38 | 7.02 | - | - | 1.18 | 0.00 | -18.40% | -11.60% |
| Vaxxinity, Inc. | 462,920,000 | -137,200,000 | 70,000 | 0.00 | 3.50 | 1.13 | - | - | 3.19 | 0.08 | - | - |
| vTv Therapeutics Inc. | 72,720,000 | -13,000,000 | 4,000,000 | 0.00 | 0.00 | 0.15 | - | - | 5.43 | 0.00 | 38.40% | -54.50% |
| Ventyx Biosciences, Inc. | 839,840,000 | -85,300,000 | 0 | 0.00 | 2.87 | 5.05 | - | - | 3.25 | 0.00 | - | - |
| VYNE Therapeutics Inc. | 25,460,000 | -73,300,000 | 14,800,000 | 0.00 | 0.47 | 0.71 | - | - | 0.60 | 0.00 | -106.50% | -68.00% |
| Exicure, Inc. | 19,230,000 | -64,099,999 | -2,460,000 | 0.00 | 1.36 | 0.33 | - | - | 0.49 | 0.62 | -229.10% | -84.00% |
| Xilio Therapeutics, Inc. | 135,820,000 | -75,800,000 | 0 | 0.00 | 0.04 | 5.85 | - | - | 0.69 | 0.05 | 176.80% | -47.60% |
| XOMA Corporation | 0 | 0 | 29,800,000 | 316.95 | 2.64 | 0.00 | 2.09 | 8.04% | 0.00 | 0.00 | - | - |